@FierceMedDev: Intuitive doubles stock buyback to quell investor angst. Article | Follow @FierceMedDev
@MarkHFierce: Haemonetics lost money in FY 2014 Q1 - Manufacturing reorg and M&A costs contributed. Yesterday's story | Follow @MarkHFierce
@DamianFierce: In case you missed it last night: GE Healthcare is recalling scanners after patient crushed to death in U.S. Report | Follow @DamianFierce
@MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. ICYMI yesterday | Follow @MichaelGFierce
> Neuronetics has kicked off a clinical trial to test how well its NeuroStar brain-stimulation device can treat women with postpartum depression. More
> Norwegian diagnostics outfit DiaGenic ($DIAG) watched its shares plummet more than 50% after its Alzheimer's test failed to meet its endpoints in a study. Article
> Life Technologies ($LIFE) has signed a 5-year deal with the FDA to use its diagnostics technology for food safety testing. News
> Regions in India are beginning to ban the use of mercury-based medical products. Story
> Implant Sciences has moved into much larger headquarters and manufacturing space in Wilmington, MA. Item
> EPGL Medical says it has developed a self-powered, self-contained power source for contact lenses that could enable, in part, the display of medical data such as blood sugar or oxygen levels. Item
> Conspiracy theories are mushrooming regarding the unexpected death of Barnaby Jack, a computer hacker who demonstrated security flaws in insulin pumps and other medical devices. Story
> Philips Healthcare ($PHG) is looking to establish an incubator for medical startups in Israel. Story
Biotech News
@FierceBiotech: PR: Adocia, Eli Lilly end collaboration; Adocia reacquires exclusive development rights to insulin analog. Release | Follow @FierceBiotech
@RyanMFierce: UPDATED: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement. Item | Follow @RyanMFierce
@EmilyMFierce: Novavax joins H7N9 vaccine race, reports positive preclinical data. Article | Follow @EmilyMFierce
> Sanofi, NEA team up in $18M round for rare disease outfit Edimer. Story
> Celgene inks $11M inflammation deal with Array BioPharma. News
> Synta Pharma rebounds on early results from drug study for breast cancer. Article
Pharma News
@FiercePharma: ICYMI: Pfizer to split operations three ways. Yesterday's story | Follow @FiercePharma
@CarlyHFierce: India's Cadila Pharma selects site for $150M plant in Russia. Article | Follow @CarlyHFierce
> Suffering from generic onslaught, Merck cuts sales forecast. Story
> Sanofi's bid for more OTC meds gets FDA boost. Article
> Moody's cuts GlaxoSmithKline outlook, citing billions in outlays. Report
Biotech Research News
@EmilyMFierce: UCLA team IDs anti-amyloid compounds to treat Alzheimer's, other brain diseases. Story | Follow @EmilyMFierce
> Novavax joins H7N9 vaccine race, reports positive preclinical data. News
> Antibody effective at fighting norovirus in chimps. Story
> Novavax joins H7N9 vaccine race, reports positive preclinical data. Article
> Antibody effective at fighting norovirus in chimps. More
Pharma Manufacturing News
@EricPFierce: Lawmakers want assurances Smithfield sale to China's Shuanghui won't leave US drugmakers short of heparin. Report | Follow @EricPFierce
> Cadila Pharma selects site for $150M Russian plant. News
> Alexion adding 50 jobs in Ireland to grow global supply chain. Item
> Pfizer says investments in Ireland position plants for growth. More
> New Russian company to build $85M plant. Story
> Bristol-Myers turns to Samsung for cancer drug. Article